Compare Honeywell International Inc (HON) vs Heron Therapeutics Inc (HRTX) Price & Performance

Honeywell International IncTrade

Heron Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

Honeywell International Inc vs Heron Therapeutics Inc — how do they compare? Honeywell International Inc trades at $230.35 (market cap $76.99B), while Heron Therapeutics Inc trades at $0.32 (market cap $63.41M). The key difference: Honeywell International Inc is far larger — about 1214.2× Heron Therapeutics Inc's market cap, and Honeywell International Inc pays a 1.15% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.

	HON	HRTX
Market Cap	$76.99B	$63.41M
Sector	Industrials	Health
52-Week High	$248.79	$1.49
52-Week Low	$188.14	$0.32
Enterprise Value	$101.79B	$161.31M
Dividend Yield	1.15%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Honeywell International Inc

No Aura AI signal available yet.

Heron Therapeutics Inc

Heron Therapeutics (HRTX) trades at $0.49, down 1.64% today, with a bearish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed earnings expectations with a $0.03 loss per share. Despite negative net income margins, HRTX maintains strong analyst support with 94.7% buy ratings. Recent news highlights patent litigation developments and quarterly earnings underperformance.

HRTX faces significant fundamental challenges with persistent losses and declining revenue projections, though analyst consensus remains overwhelmingly bullish. Investment opportunity exists if the company can achieve profitability and meet growth targets, but risks include ongoing operational losses, competitive pressures, and execution challenges in the biotechnology sector.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HON

Honeywell raises guidance, targets 4-6% growth and strong cash flow through 2029Seeking Alpha · 18 hours agoBullish Honeywell shares drop 4.7% after weak aerospace spin-off results and cautious growth outlook.24/7 Wall Street · 18 hours agoBearish Honeywell Aerospace shares plunge 20% post-spin-off, dragging down Honeywell International's outlook.Alex Lavoie · 2 days agoBearish View details →

HRTX

Heron Therapeutics misses Q2 earnings and revenue estimates, pauses sales expansion, withdraws full-year outlook.Alex Lavoie · 1 day agoBearish View details →

About Honeywell International Inc

Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.